HANSEN JOHN DAVID

Insider CIK 1186123 · MBVX President and CEO, Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise deriv	2018-04-02	2018-04-03	13,561	—	$0	0	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise	2018-04-02	2018-04-03	13,561	—	$0	195,516	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	F Tax w/h	2018-04-02	2018-04-03	4,689	—	$0	190,827	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2018-02-21	2018-02-23	290,000	—	$0	290,000	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2018-01-16	2018-01-18	59,263	$0.92	$54.5K	536,730	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2018-01-12	2018-01-16	18,582	$0.96	$17.8K	595,993	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2018-01-11	2018-01-16	64,015	$0.98	$62.7K	614,575	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2018-01-10	2018-01-16	110,093	$0.96	$105.7K	678,590	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise deriv	2018-01-08	2018-01-16	727,210	—	$0	0	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise	2018-01-08	2018-01-16	727,210	—	$0	788,683	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2017-10-02	2017-10-04	551,156	—	$0	551,156	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2017-09-15	2017-09-18	176,054	—	$0	176,054	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale deriv	2017-05-19	2017-08-02	3,119	—	$0	0	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale deriv	2017-05-19	2017-08-02	3,119	—	$0	0	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	P Buy	2017-05-19	2017-08-02	4,286	$1.75	$7.5K	65,759	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	P Buy	2017-05-19	2017-08-02	4,842	—	$0	70,601	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2017-05-19	2017-05-23	500,000	$2.00	$1.00M	500,000	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-12	2017-04-14	10,216	$2.00	$20.4K	61,473	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-11	2017-04-11	250	$2.00	$500	71,689	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-10	2017-04-11	560	$2.00	$1.1K	71,939	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-07	2017-04-11	666	$2.01	$1.3K	72,499	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-06	2017-04-06	1,501	$2.15	$3.2K	73,165	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-05	2017-04-06	2,450	$2.15	$5.3K	74,666	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-04	2017-04-06	1,100	$2.25	$2.5K	77,116	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise deriv	2017-04-02	2017-04-04	40,687	—	$0	40,687	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise	2017-04-02	2017-04-04	40,687	—	$0	78,216	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2017-02-06	2017-02-08	250,000	$2.99	$747.5K	250,000	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2017-01-01	2017-01-03	63,400	$3.38	$214.3K	63,400	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2016-08-29	2016-08-30	63,400	$5.00	$317.0K	63,400	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	P Buy deriv	2016-08-17	2016-08-19	3,119	—	$0	3,119	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	P Buy deriv	2016-08-17	2016-08-19	3,119	—	$0	3,119	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	P Buy	2016-08-17	2016-08-19	3,119	—	$0	37,529	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise deriv	2016-04-04	2016-04-05	301,184	—	$0	602,166	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise	2016-04-04	2016-04-05	301,084	—	$0	367,782	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	F Tax w/h	2016-04-04	2016-04-05	113,148	—	$0	254,634	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2016-02-16	2016-02-18	500,000	$0.49	$245.0K	500,000	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2015-04-02	2015-04-03	903,250	$2.30	$2.08M	903,250	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2015-04-02	2015-04-03	903,250	—	$0	903,250	SEC↗